NEW YORK (GenomeWeb News) – GeneNews today said that it has signed an agreement with Centcor granting the drug firm selected access to research from its osteoarthritis genomic biomarker program.
 
Heiner Dreissman, interim CEO and lead director of GeneNews, said in a statement that the firm’s Sentinel Principle, its biomarker-discovery platform, was validated around osteoarthritis. He added that the collaboration is “a source of non-dilutive funding that will contribute to our commercialization efforts.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.